123tejas

The issue is highly intertwined with religion. You will find Muslim Kashmiris that side with Pakistan and Hindu Kashmiris that side with India. The argument then devolves into who was there first, and who displaced who, and who are there more of now. It's not too unlike Israel/Palestine.

I don't know enough about the issue to comment more, but I think it's important to understand that perspectives on Kashmir are diverse and the opinion of one Muslim Kashmiri student on Reddit shouldn't be taken as gospel.

Why bother? Supposing North and South Koreans can travel without much issue like the US and Canada.

Psychedelics don't work like other treatment options for depression and anxiety.

For example with benzos you're taking a drug that increases the effectiveness of GABA and thereby puts you into an anxiety free state.

Psychedelics seem to alter your conscious state for a few hours (4-12 depending on shrooms or acid), and within this period steps can be made to improve long term outcomes for mental health. This is why psychedelic therapy is always cautioned with "in a controlled therapeutic setting".

If you are someone with depressive or anxious (overly self critical or self conscious) thoughts, and you take LSD or psilocybin, you might be able to work through your problems more rapidly during the trip, sort of like an intense form of Cognitive Behavior Therapy.

If you take psychs without proper precautions or in an unsafe environment, it's entirely possible that you could have a bad experience that has long term negative effects. Bad trips are basically just panic attacks, which in turn lead to PTSD.

TL;DR: With psychs it's all about the experience you have on the drug, which is controlled by set and setting, and less about the chemical itself directly affecting parts of the brain that deal with anxiety and depression.

Do you see street MDMA being rescheduled at a federal level? Or will we have a Dronabinol/THC sort of scheduling?

That's a shame, here's hoping medicalization will in turn lead to adjusting drug legislation on the state level.